3JYT image
Deposition Date 2009-09-22
Release Date 2009-10-06
Last Version Date 2023-09-06
Entry Detail
PDB ID:
3JYT
Title:
K65R mutant HIV-1 reverse transcriptase cross-linked to DS-DNA and complexed with DATP as the incoming nucleotide substrate
Biological Source:
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.28
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
P 31 1 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Reverse transcriptase/ribonuclease H
Gene (Uniprot):gag-pol
Mutations:K65R, Q258C, C280S
Chain IDs:A
Chain Length:558
Number of Molecules:1
Biological Source:Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
Polymer Type:polypeptide(L)
Molecule:p51 RT
Gene (Uniprot):gag-pol
Mutations:C280S
Chain IDs:B
Chain Length:437
Number of Molecules:1
Biological Source:Human immunodeficiency virus type 1 group M subtype B (isolate BH10)
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*A*CP*AP*GP*TP*CP*CP*CP*TP*GP*TP*TP*CP*GP*GP*(MRG)P*CP*GP*CP*CP*(DDG))-3')
Chain IDs:D (auth: P)
Chain Length:21
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(*A*TP*GP*GP*TP*CP*GP*GP*CP*GP*CP*CP*CP*GP*AP*AP*CP*AP*GP*GP*GP*AP*CP*TP*GP*TP*G)-3')
Chain IDs:C (auth: T)
Chain Length:27
Number of Molecules:1
Biological Source:synthetic construct
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MRG D DG ?
Primary Citation
Structural basis for the role of the K65r mutation in HIV-1 reverse transcriptase polymerization, excision antagonism, and tenofovir resistance.
J.Biol.Chem. 284 35092 35100 (2009)
PMID: 19812032 DOI: 10.1074/jbc.M109.022525

Abstact

K65R is a primary reverse transcriptase (RT) mutation selected in human immunodeficiency virus type 1-infected patients taking antiretroviral regimens containing tenofovir disoproxil fumarate or other nucleoside analog RT drugs. We determined the crystal structures of K65R mutant RT cross-linked to double-stranded DNA and in complexes with tenofovir diphosphate (TFV-DP) or dATP. The crystals permit substitution of TFV-DP with dATP at the dNTP-binding site. The guanidinium planes of the arginines K65R and Arg(72) were stacked to form a molecular platform that restricts the conformational adaptability of both of the residues, which explains the negative effects of the K65R mutation on nucleotide incorporation and on excision. Furthermore, the guanidinium planes of K65R and Arg(72) were stacked in two different rotameric conformations in TFV-DP- and dATP-bound structures that may help explain how K65R RT discriminates the drug from substrates. These K65R-mediated effects on RT structure and function help us to visualize the complex interaction with other key nucleotide RT drug resistance mutations, such as M184V, L74V, and thymidine analog resistance mutations.

Legend

Protein

Chemical

Disease

Primary Citation of related structures